Your browser doesn't support javascript.
loading
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.
Sutton, Lesley-Ann; Young, Emma; Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Moysiadis, Theodoros; Plevova, Karla; Rossi, Davide; Kminkova, Jana; Stalika, Evangelia; Pedersen, Lone Bredo; Malcikova, Jitka; Agathangelidis, Andreas; Davis, Zadie; Mansouri, Larry; Scarfò, Lydia; Boudjoghra, Myriam; Navarro, Alba; Muggen, Alice F; Yan, Xiao-Jie; Nguyen-Khac, Florence; Larrayoz, Marta; Panagiotidis, Panagiotis; Chiorazzi, Nicholas; Niemann, Carsten Utoft; Belessi, Chrysoula; Campo, Elias; Strefford, Jonathan C; Langerak, Anton W; Oscier, David; Gaidano, Gianluca; Pospisilova, Sarka; Davi, Frederic; Ghia, Paolo; Stamatopoulos, Kostas; Rosenquist, Richard.
Afiliação
  • Sutton LA; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Young E; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Hadzidimitriou A; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Moysiadis T; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Plevova K; Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
  • Rossi D; Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Kminkova J; Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
  • Stalika E; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Pedersen LB; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Malcikova J; Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
  • Agathangelidis A; Università Vita-Salute San Raffaele, Milan, Italy Division of Experimental Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy.
  • Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Mansouri L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Scarfò L; Università Vita-Salute San Raffaele, Milan, Italy Division of Experimental Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy.
  • Boudjoghra M; Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.
  • Navarro A; Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.
  • Muggen AF; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
  • Yan XJ; The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, NY, USA.
  • Nguyen-Khac F; Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.
  • Larrayoz M; Cancer Sciences, Faculty of Medicine, University of Southampton, UK.
  • Panagiotidis P; First Department of Propaedeutic Medicine, University of Athens, Greece.
  • Chiorazzi N; The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, NY, USA.
  • Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Belessi C; Hematology Department, Nikea General Hospital, Piraeus, Greece.
  • Campo E; Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.
  • Strefford JC; Cancer Sciences, Faculty of Medicine, University of Southampton, UK.
  • Langerak AW; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
  • Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Gaidano G; Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Pospisilova S; Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic.
  • Davi F; Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.
  • Ghia P; Università Vita-Salute San Raffaele, Milan, Italy Division of Experimental Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy.
  • Stamatopoulos K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden Institute of Applied Biosciences, CERTH, Thessaloniki, Greece Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden richard.rosenquist@igp.uu.se.
Haematologica ; 101(8): 959-67, 2016 08.
Article em En | MEDLINE | ID: mdl-27198719

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Leucemia Linfocítica Crônica de Células B / Biomarcadores Tumorais / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Haematologica Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Leucemia Linfocítica Crônica de Células B / Biomarcadores Tumorais / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Haematologica Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia